Groundbreaking new data from Longevity.Technology reveals that Troculeucel is making promising strides in Alzheimer’s treatment by potentially enhancing cognition in patients. The recent study highlights that Troculeucel, an innovative therapy, may significantly boost cognitive functions, offering hope in the battle against Alzheimer’s disease. As Alzheimer’s continues to affect millions globally, this development could mark a pivotal advancement in neurological health. Researchers are optimistic about Troculeucel’s potential to slow cognitive decline, suggesting a paradigm shift in Alzheimer’s care. The study’s findings are a beacon of hope, strengthening the possibility of improved quality of life for those living with this challenging condition. These insights are crucial for further exploration and research in the field of neurodegenerative diseases.
Longevity.TechnologyNew data shows increase in IHT receipts according to latest HMRC report
March 21, 2026
The latest figures from HM Revenue and Customs (HMRC) reveal a notable increase in inheritance tax (IHT) receipts, highlighting significant trends in the lending and